This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥429209 individuals
Apply sex-specific rule
189303
Check conditions None
189303
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
12
Check minimum number of events None
12
Include endpoints None
12
Remove individuals based on genotype QC
12
Control definitions
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Testicular hyperfunction based on the number of shared cases.
Broader endpoints:
- Testicular dysfunction
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Gastrointestinal diseases
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 12 | - | 12 |
Unadjusted prevalence (%) | 0.00 | - | 0.01 |
Mean age at first event (years) | 53.41 | - | 53.41 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_TESTICHYPER – Testicular hyperfunction
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Testicular hyperfunction
↥Endpoint not on priority list, no data to show.